4//SEC Filing
CHEN ISAN 4
Accession 0001214659-20-004484
CIK 0001576263other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:18 PM ET
Size
9.2 KB
Accession
0001214659-20-004484
Insider Transaction Report
Form 4
CHEN ISAN
Chief Medical & Dev't Officer
Transactions
- Exercise/Conversion
Common Stock
2020-05-11$24.99/sh+33,334$833,017→ 72,735 total - Sale
Common Stock
2020-05-11$105.00/sh−33,334$3,500,070→ 39,401 total - Exercise/Conversion
Stock Options
2020-05-11−33,334→ 23,420 totalExercise: $24.99Exp: 2026-01-21→ Common Stock (33,334 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2019.
- [F2]This transaction was executed in multiple trades at prices ranging from $105.00 to $105.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001586218
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:18 PM ET
- Size
- 9.2 KB